AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Summary

Investigational drug AMG 714 will be given to 66 subjects with moderate to severe psoriasis to study safety, pharmacokinetics, and efficacy. Dose levels include 150mg and 300mg and will be given to each subject for a total of 6 doses. Each dose for each subject will be given once every 2 weeks. Subjects will followed for up to 300 days post the first dose of AMG 714.

Timeline

Start

2007-03

Primary completion

2008-12

Completion

2010-05

Drugs

Indications